Prescription Drugs - Southern Africa

  • Southern Africa
  • The Prescription Drugs market in Southern Africa is projected to reach a revenue of US$4.71bn in 2024.
  • The market is expected to exhibit an annual growth rate (CAGR 2024-2029) of 5.07%, leading to a market volume of US$6.03bn by 2029.
  • When compared globally, United States is anticipated to generate the highest revenue of US$358.90bn in 2024.
  • In terms of per person revenues, in Southern Africa is estimated to generate US$67.23 in 2024.
  • Southern Africa is experiencing a rise in demand for generic prescription drugs due to their cost-effectiveness and accessibility.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Southern Africa is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this growth. Customer preferences in Southern Africa are driving the development of the Prescription Drugs (Pharmacies) market. Customers in this region are increasingly seeking convenient and accessible healthcare options. They value pharmacies that offer a wide range of prescription drugs, as well as over-the-counter medications and health products. This preference for a one-stop-shop experience is fueling the growth of pharmacies in the region. Trends in the market further support the development of the Prescription Drugs (Pharmacies) market in Southern Africa. One notable trend is the increasing prevalence of chronic diseases in the region, such as diabetes and hypertension. As a result, there is a growing demand for prescription drugs to manage these conditions. Pharmacies are capitalizing on this trend by expanding their range of prescription medications and offering specialized services to support patients with chronic diseases. Another trend driving the growth of the Prescription Drugs (Pharmacies) market in Southern Africa is the increasing focus on preventive healthcare. Customers are becoming more proactive in managing their health and are seeking out pharmacies that offer wellness services and health screenings. Pharmacies are responding to this trend by offering services such as vaccinations, health consultations, and lifestyle advice. This emphasis on preventive healthcare is contributing to the overall growth of the market. Local special circumstances also play a role in the development of the Prescription Drugs (Pharmacies) market in Southern Africa. In many countries in the region, there is limited access to healthcare facilities, particularly in rural areas. Pharmacies are filling this gap by providing accessible healthcare services, including prescription drugs. They are often the first point of contact for individuals seeking medical advice and treatment. This unique circumstance has led to the expansion of pharmacies in the region. Underlying macroeconomic factors are also contributing to the growth of the Prescription Drugs (Pharmacies) market in Southern Africa. The region is experiencing economic growth, leading to an increase in disposable income and healthcare spending. As a result, individuals have greater purchasing power to afford prescription drugs and other healthcare products. This economic growth is creating a favorable market environment for pharmacies to thrive. In conclusion, the Prescription Drugs (Pharmacies) market in Southern Africa is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for convenient and accessible healthcare options, the increasing prevalence of chronic diseases, the focus on preventive healthcare, limited access to healthcare facilities, and economic growth all contribute to the growth of the market. Pharmacies in Southern Africa are well-positioned to meet the evolving healthcare needs of the population and continue to expand their services.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)